MSCs in Umbilical Cord Tissue and Wharton's Jelly

Wharton's jelly — the gelatinous connective tissue of the umbilical cord — spent a century and a half as an anatomical footnote. It is now recognized as one of the richest accessible sources of mesenchymal stromal cells in the human body, and the foundation of an entire class of preparations.

What lives in the jelly

The cord's stroma houses stromal cell populations that meet the ISCT's defining criteria — plastic adherence, the characteristic surface-marker profile, tri-lineage differentiation capacity. Published characterization places them among the more primitive stromal populations accessible after birth: younger than adult marrow or adipose-derived cells, with higher proliferative capacity and a strongly immunomodulatory secretome.

The sourcing advantage

Bone marrow requires an invasive harvest from an adult donor of advancing age. Cord tissue is donated at birth from screened, consented deliveries — an ethically uncomplicated source of neonatal cells at the very start of their replicative lifespan. Every quality curve that declines with donor age starts higher here.

From theory to applied science

Twenty years ago this was academic literature. Today it is a manufacturing discipline: donor eligibility under 21 CFR Part 1271, cryopreservation, ISCT-aligned characterization, and per-lot documentation. The preparations Med Plug RX distributes — cord tissue, Wharton's jelly and cord blood derived — are the applied form of the science summarized here, with the paper trail that lets a physician verify it.